2020
DOI: 10.7150/thno.42445
|View full text |Cite
|
Sign up to set email alerts
|

Bio-orthogonal click-targeting nanocomposites for chemo-photothermal synergistic therapy in breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(17 citation statements)
references
References 53 publications
0
17
0
Order By: Relevance
“…However, long-term application of a single photothermal therapy may cause the overexpression of heat shock protein, leading to the heat tolerance of tumors. Combination therapy, such as chemo-photothermal therapy, is widely used to overcome this obstacle [ 88 90 ]. Zhang et al [ 91 ] synthesized PEG (polyethylene glycol)-modified MPDA (MPDA-PEG) via an emulsion-induced interface assembly method.…”
Section: Mesoporous Polydopamine Applications In Tumor Therapymentioning
confidence: 99%
“…However, long-term application of a single photothermal therapy may cause the overexpression of heat shock protein, leading to the heat tolerance of tumors. Combination therapy, such as chemo-photothermal therapy, is widely used to overcome this obstacle [ 88 90 ]. Zhang et al [ 91 ] synthesized PEG (polyethylene glycol)-modified MPDA (MPDA-PEG) via an emulsion-induced interface assembly method.…”
Section: Mesoporous Polydopamine Applications In Tumor Therapymentioning
confidence: 99%
“…Qiao and co-workers developed a copper-free click-targeting LMWH-quercetin nanocomposite system (DLQ/DZ) that improved the specific co-delivery of doxorubicin and the photosensitizer zinc phthalocyanine (PTT application) against breast cancer cells by glycoengineering the tumor cell surface with an azide-modified sugar (Ac4ManN 3 ) (Figure 25). 223 This co-treatment combination (chemotherapeutic agent and PTT) was studied because it is known that PTT enhances tumor sensitivity to chemotherapeutic agents. The use of artificial receptors and the glycoengineering system necessitated this synergic treatment (with intratumoral rather than intravenous injection of Ac4ManN 3 ).…”
Section: Nps Using Click Chemistry For a Theranostic Approachmentioning
confidence: 99%
“…More recently, the team of Yao investigated a similar targeting protocol for the chemo‐photothermal therapy of breast tumours (Figure 15, entry 2) [64] . They developed DBCO‐functionalised nanocomposites designed for the simultaneous delivery of doxorubicin and a photosensitiser (zinc phthalocyanine).…”
Section: In Vivo Bioorthogonal Chemistry For Therapeutic Applicationsmentioning
confidence: 99%